What does Taikang Asset invest in?
Taikang Asset invests most often at Series B and Series C (75% of the rounds on record), in sectors such as E-Commerce, Flowers and Asset Management.
China · Investor
No cheque observed since Apr 2019, after 4 earlier cheques, and the website is dead.
DormantGrowth equity
4 rounds on record
Mostly Series B and Series C: 75% of its rounds
Every round we can evidence, newest first4 appearances
2 rounds
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The investors most often in the same rounds as Taikang Asset. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Taikang Asset put money into.
Taikang Asset invests most often at Series B and Series C (75% of the rounds on record), in sectors such as E-Commerce, Flowers and Asset Management.
4 investments on record, 0 of them in the last 12 months. The most recent was in Apr 2019.
Its most recent investments on record: Shanghai LinkedCare Information Technology (Series C, Apr 2019), Antengene (Series B, Jan 2019) and Just Biotherapeutics (Series B, Jun 2018).
The median round it joins is $78M.
It looks quiet: no investment on record since Apr 2019.
Most often Lilly Asia Ventures (2 rounds together).
Taikang Asset is a growth equity firm based in 北京, China.
Taikang Asset was founded in 2006.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it